It is reported that the pediatric population with CD4+ T lymphocyte levels lower than <15% (severe immunodeficiency) have a higher risk of developing severe forms, relapses, infection from multiresistant strains, adverse reactions to antituberculous drugs and higher mortality [2, 16]. The gene discussed is CD4; the disease is immunodeficiency disease.